Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NGL Fine-Chem is a leading Indian pharmaceutical company specializing in the manufacture of Active Pharmaceutical Ingredients (APIs) and intermediates for both veterinary and human health. Established in 1981, the company has carved a niche in the global veterinary market, particularly in anthelmintics and ectoparasiticides. With state-of-the-art manufacturing facilities in Maharashtra, NGL Fine-Chem exports its products to over 50 countries, maintaining high quality standards such as GMP. The company is publicly traded on the Indian stock exchanges and is known for its robust process development and chemical synthesis capabilities. Its portfolio includes key products like Nitroxynil, Closantel, and Oxyclozanide, serving major global animal health companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NGL Fine-Chem.